A preliminary quantitative proteomic analysis of glioblastoma pseudoprogression

Conclusions: The results of the present study both revealed the biological signatures of PsPD from a proteomics perspective and indicated that CDH2 alone or combined with ELAVL1 could be potential biomarkers with high accuracy in the diagnosis of PsPD.
Source: Proteome Science - Category: Bioinformatics Authors: Source Type: research